Israel Englander’s Invesco Biotechnology & Genome ETF PBE Stock Holding History

Israel Englander’s Portfolio PBE Stock Details PBE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-4,050	Closed	-$205K	–	3563
2015 Q4	$205K	Buy	+4,050	New	+$200K	﹤0.01%	3078
2015 Q3	–	Sell	-4,673	Closed	-$273K	–	3659
2015 Q2	$273K	Sell	4,673 -7,138	-60%	-$408K	﹤0.01%	2924
2015 Q1	$651K	Sell	11,811 -70	-0.6%	-$3.78K	﹤0.01%	2590
2014 Q4	$596K	Buy	+11,881	New	+$581K	﹤0.01%	2868

Other funds holding PBE

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

TAM

Trillium Asset Management Boston, Massachusetts $3.25B AUM 23.6% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

TCM

Traynor Capital Management Malvern, Pennsylvania $2.18B AUM 62.36% 1-Year Est. Return

HBT

Hills Bank & Trust North Liberty, Iowa $2.35B AUM 17.18% 1-Year Est. Return

CAS

Cue Advisory Services Phoenix, Arizona $167M AUM 18.62% 1-Year Est. Return

Israel Englander's PBE Position: Q1 2016 in Review

Israel Englander sold out of Invesco Biotechnology & Genome ETF (PBE) in Q1 2016, closing a stake of 4,050 shares — an estimated $205K sold.

Israel Englander first reported a position in PBE in Q4 2014 and held it in 4 quarters. The position peaked at $651K in Q1 2015. 71 funds tracked by Wall St. Rank hold PBE as of Q1 2016.

Israel Englander reported no remaining Invesco Biotechnology & Genome ETF position as of Q1 2016 after selling out during the quarter.
Israel Englander sold 4,050 Invesco Biotechnology & Genome ETF shares in Q1 2016, an estimated $205K.
Israel Englander first reported a position in Invesco Biotechnology & Genome ETF in Q4 2014 and held it in 4 quarters.
Israel Englander's Invesco Biotechnology & Genome ETF position peaked at $651K in Q1 2015.
71 funds tracked by Wall St. Rank held Invesco Biotechnology & Genome ETF as of Q1 2016.

Based on Millennium Management's 13F filing for Q1 2016, filed 16 May 2016.